This inventor holds 1 USPTO granted patent. Top assignee: Novartis Corporation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Olivier Tinembart: Innovator in Pharmaceutical Chemistry
Introduction
Olivier Tinembart is a notable inventor based in Delemont, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a valuable asset in the industry.
Latest Patents
Olivier holds a patent for a compound described as 1-N-(halo-3-pyridylmethyl)!-N-methylamino-1-alklamino-2-nitroethylene. This compound is characterized by the formula I, where Hal represents halogen elements such as fluorine, chlorine, bromine, or iodine. His work in this area showcases his commitment to advancing pharmaceutical applications.
Career Highlights
Olivier is currently employed at Novartis Corporation, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His career reflects a strong focus on innovation and the application of scientific knowledge to improve health outcomes.
Collaborations
Olivier has worked alongside talented colleagues, including Thomas Friedel and Eric William Moyses. These collaborations have fostered a dynamic environment for creativity and innovation, further enhancing the impact of their collective work in the pharmaceutical sector.
Conclusion
Olivier Tinembart is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His patent work and collaborations reflect his commitment to innovation and excellence in the field. Through his efforts, he continues to make a significant impact on healthcare advancements.